Norma Group Se · XETR:NOEJ
Norma — Q3 2020 Earnings Presentation
80 slides from Norma's earnings presentation, November 2020
Slide 1: NORMA Group SE Third Quarter 2020 Results
NORMA Group SE Third Quarter 2020 Results 1
Slide 2: Agenda
Facts & Figures Q3 2020 p. 3 Top Line, P&L & Segment Reporting p. 4-9 (Net) Debt & Maturity Profile p. 10-11 Cash Flow and NOVA p. 12-13 Outlook and Guidance p. 14-15 Appendix: FY 2019 Figures p. 16-50 Business Modell, Track Record & CSR p. 51-75 Share Information and others p. 76-80 2
Slide 3: Facts & Figures Q3 2020
Sales Sales down by –10.2% to EUR 245.9 million (Q3 2019: EUR 274.0 million) Adjusted EBITA Adjusted EBITA at EUR 28.7 million (Q3 2019: EUR 38.7 million), including EUR 1.5 million costs (margin) related to the change program "Get on track"; adjusted EBITA margin of 11.7% (Q3 2019: 14.1%) Adjusted
Slide 4: Sales
Thereof Thereof Sales 2019 2020 Change Change in % organic currency Q1 275.6 253.6 -22.0 -8.0% -8.9% 0.9% Q2 289.0 191.5 -97.6 -33.8% -33.9% 0.1% Q3 274.0 245.9 -28.0 -10.2% -7.5% -2.7% Q1-Q3 838.6 691.0 -147.7 -17.6% -17.1% -0.5% • Organic decline of 7.5% in Q3 2020 resulting from − a still weak (C
Slide 5: Sales by region
EMEA EMEA AM APAC EMEA AM APAC • EJT: COVID-19 pandemic-related organic decline 10 of 23.8% in Q1-Q3 2020, even though Q3 2020 200 showed sequential recovery (Q3 2020: -11.9%) 1.7 2.1 Q3 2019 0 Q3 2019 • DS: organic decline of 17.6% in Q1-Q3 2020 (Q3 2020: -13.9%) due to destocking and economic 100
Slide 6: Adjusted EBITA and EBITDA margin development
• Economic recovery in Q3 and strict cost control measures resulting in an EBITDA margin of 16.3% and an adjusted EBITA margin of 11.7% • EBITDA margin excl. costs related to the "Get on track" change program at 13.1% in Q1-Q3 2020 • Adjusted EBITA margin excl. costs related to the "Get on track" ch
Slide 7: Cost ratios
• Material cost ratio decreased due to a decrease in inventories of finished goods and work in progress • Gross profit margin decreased in Q3 2020 by 90 BPs to 57.1% due to favorable destocking and some inventory write-offs • Personnel expenses ratio decreased by 30 BPs to 27.2% in Q3 2020 (Q3 2019:
Slide 8: Reported to adjusted earnings Q1-Q3 2020
• No adjustment of costs related to the "Get on track" change program leading to the same reported and adjusted EBITDA • EUR 23.7 million costs related to the "Get on track" change program in Q1-Q3 2020 are not shown on an adjusted basis • Ongoing PPA adjustments of EUR 18.8 million on EBIT level •
Slide 9: Earnings per share
• Adjusted and reported EPS negatively impacted by the COVID-19 pandemic and costs related to the change program "Get on track" EUR EUR EUR EUR 2 3 2 2 2 1 1.61 1 1 2.33 1 0 -0.17 0.73 0.50 0.27 0.52 0.36 0 0 0 -1 Q3 2019 Q3 2020 Q1-Q3 2019 Q1-Q3 2020 Q3 2019 Q3 2020 Q1-Q3 2019 Q1-Q3 2020 9
Slide 10: Net debt, equity ratio and leverage
• Equity Ratio down by 70 BPs to 40.9 % (Dec. 31, 2019: 41.6%) mainly due to negative currency effects and net loss for the period • Leverage decreases to 3.6 x compared to Q2 2020 (June 30, 2020: 3.7 x) showing sequential improvement • Leverage excluding the costs related to the "Get on track" chan
Slide 11: Maturity profile and covenants
300 EUR 15 million already 45 prolonged and extended 200 to EUR 30 million 248 100 15 65 EUR 29 million 42 already repayed 29 35 21 42 0 2020 2021 2022 2023 2024 2025 2026 Bank Borrowings Promissory Note 1 Promissory Note 2 Promissory Note 3 CP Program • Solid long-term maturity profile • No covenan
Slide 12: Net operating cash flow
Q1-Q3 Q1-Q3 in EUR million Q3 2019 Q3 2020 Variance* Variance* 2019 2020 (Adjusted) EBITDA 49.4 40.1 -9.3 150.6 66.6 -84.0 Δ ± Trade Working capital -1.3 7.8 +9.1 -49.9 4.2 +54.1 Net operating cash flow before investments 48.0 47.9 -0.1 100.7 70.8 -29.9 from operating business Δ ± Investments from o
Slide 13: NORMA Value Added (NOVA)
in EUR million Q3 2019 Q3 2020 Q1-Q3 2019 Q1-Q3 2020 Adjusted EBIT after taxes 26.1 18.4 82.4 19.0 Capital Cost (WACC x CE per January 1st) 18.1 21.2 53.2 62.4 NOVA 8.1 -2.8 29.2 -43.5 • NORMA Group determines the annual value creation in form of the so-called NORMA Value Added (NOVA) • NOVA is NORM
Slide 14: Get on track program accelerated
• "Get on track" program has been accelerated also due to COVID-19 pandemic • EUR 23.7 million costs in Q1-Q3 2020 related to location projects lead to increased costs in 2020 of EUR 30 million • First benefits include improvements in purchasing and product portfolio 2020 2021 2022 2023 2024 ongoing
Slide 15: Guidance 2020
Organic decline of around 16% compared to the EMEA: significant organic decline; Americas: significant previous year organic decline; APAC: noticeable organic decline EJT: significant decline More than 5%* DS: noticeable decline More than 4%* Around 5% of EJT sales Higher than in the previous year M
Slide 16: Appendix
[aNSEBA Appendix
Slide 17: Appendix agenda
Facts & Figures Full Year 2019 p. 19-21 Segments and P&L Statement p. 22-35 Balance Sheet Development p. 36-41 Cash Flow and NOVA p. 42-44 Outlook and Guidance p. 45-51 Business Model and Track Record p. 52-72 Corporate Responsibility p. 73-76 Share Information p. 77-80 17
Slide 18: Facts & Figures FY 2019
Facts & Figures FY 2019
Slide 19: FY 2019 facts and figures: sales, EBITA, EPS
Sales Sales at EUR 1,100.1 million (2018: EUR 1,084.1 million); growth of 1.5% Organic Organic decline of -2.0% in 2019 (2018: +7.7%) revenue Adjusted Adjusted EBITA at EUR 144.8 million (2018: EUR 173.2 million) EBITA Margin Adjusted EBITA margin at 13.2% (2018: 16.0%) Adjusted EPS at EUR 2.76 (201
Slide 20: FY 2019 balance sheet, cash flow and dividend
Strong balance sheet with an equity ratio of 41.6% (2018: 40.9%) despite dividend payments and higher Equity balance sheet total Net debt increased to EUR 420.8 million (2018: EUR 400.3 million) including dividend payments and Net Debt IFRS16 Leverage Net debt / adj. EBITDA leverage increased to 2.2
Slide 21: Profit & Loss, Segment Reporting
Profit & Loss, Segment Reporting
Slide 22: Sales 2019
thereof thereof thereof Sales 2018 2019 Change Change in % organic acquisitions currency Q1 272.6 275.6 + 3.0 + 1.1% - 4.2% + 2.3% + 3.1% Q2 276.4 289.0 + 12.6 + 4.6% - 0.4% + 2.4% + 2.5% Q3 268.1 274.0 + 5.9 + 2.2% - 0.1% + 0.2% + 2.1% Q4 267.0 261.4 - 5.6 - 2.1% - 3.3% 0.0% + 1.2% FY 1,084.1 1,100
Slide 23: Sales development since 2007
CAGR ~ 9% 1200 2011 65.6 13.4% 1000 2012 -10.8 -1.9% 2013 15.1 2.5% 800 2014 41.3 6.5% 600 2015 25.9 3.7% 1,084 1,100 1,017 2016 7.6 0.9% 890 895 400 695 2017 77.0 8.6% 605 636 581 458 490 2018 78.6 7.7% 200 385 330 2019 -21.6 -2.0% 0 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Slide 24: EMEA sales development
• Weak automotive sector led to decline in EJT of -2.4%, 500 20 3% 2.0% while DS was also trending down in Q4 with -1.9% for the 400 2% full year 10 9.5 1% 300 • 495 0 0% 486 200 -11.4 -1% Acquisition of Statek had a positive impact of EUR 3 million -10 or 0.6% on group sales 100 -2% -20 -2.3% -3% •
Slide 25: Americas sales development
• 500 60 12.4% 15% Strong organic growth of NDS was more than offset by strong organic decline of EJT business (especially in Q4) 400 40 10% caused by strikes and weak automotive business 300 51.2 • 20 5% 200 442 451 0 0% No M&A effects in the Americas in 2019 100 -13.6 • -20 -3.1% -5% 0 2018 2019 E
Slide 26: Asia-Pacific sales development
• Despite a very weak Chinese market, EJT grow moderately 200 20 20% with a very good recovery in Q4. DS with a slightly positive 14.9% organic growth, resulting for the region in an overall 150 15 15% moderate organic growth of 2.3% 10 10% • 100 148 163 The acquisition of Kimplas had a positive eff
Slide 27: Sales split EJT and DS
thereof water management thereof industrial supplier 20% (17%) 32% (33%) DS EJT = Engineered Joing Technology 39% (37%) DS = Distribution Services EJT 61% (63%) 19% (20%) thereof general distribution products 9% (10%) thereof 20% commercial vehicle OEM (20%) thereof passenger vehicle OEM * FY 2019 (
Slide 28: Cost ratios 2019
• Material costs ratio improved by 20 BP with stabilizing raw material prices and lower changes in inventories compared to prior year • Personnel cost ratio higher at 27.5% (2018: 25.9%) due to payments for a former board member and prior years’ bonus provision release • Other operating income and e
Slide 29: EBITDA, EBITA and EBIT margins
24% 20% 17.4% 17.7% 17.4% 17.7% 17.5% 17.6% 17.6% 17.2% 16.0% 16% 17.1% 16.8% 16.9% 16.5% 16.7% 16.6% 16.5% 16.3% 15.2% 13.2% 14.2% 12% 12.4% 13.5% 8% 4.8% 4% 3.9% 0% 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 Q1-Q3 Q1-Q3 2019 2020 EBITDA adjusted EBITDA reported EBITA adjusted EBITA reported
Slide 30: Adjustments
+ Acquisition and Rightsizing Costs* 17.5 16.8 0 0 6.9 3.6 4.8 3.5 4.4 13.4 + PPA Depreciation 3.0 1.2 0.3 0.5 1.3 2.2 2.3 4.2 4.0 3.5 Total Adjustments 20.5 18.0 0.3 0.5 8.2 5.8 7.1 7.7 8.4 16.9 + Acquisition and Rightsizing Costs* 17.5 16.8 0 0 6.9 3.6 4.8 3.5 4.4 13.4 + PPA Depreciation 3.0 1.2 0
Slide 31: Reported to adjusted earnings 2019
• Operational adjustments on EBITDA level mainly due to the rightsizing program • Additional PPA adjustments of EUR 26 million on EBIT level from past acquisitions • Total adjustments per share of EUR 0.93 Sales 1,100.1 1,100.1 EBITDA 173.8 13.4 187.2 (incl. EUR 0.4 million integration costs and EUR
Slide 32: Expected adjustments
• Costs for "Get on track" change program will not be adjusted • Ongoing PPA adjustments slightly decreasing over time • Adjustments on EPS level declining in the upcoming years** 13.4 EBITDA level (incl. EUR 0.4 million integration costs and EUR 13.1 0 0 million Rightsizing costs) 16.9 ca. 3 ca. 2
Slide 33: Earnings per share
EUR EUR 4 4 3 3 2 2 3.61 2.76 2.88 1 1 1.83 0 0 2018 2019 2018 2019 33
Slide 34: Income statement
Sales 1,084.1 1,100.1 1,084.1 1,100.1 Gross Profit 626.6 630.6 626.2 630.4 EBITDA 201.4 187.2 197.0 173.8 in % of sales 18.6% 17.0% 18.2% 15.8% EBITA 173.2 144.8 164.8 127.9 in % of sales 16.0% 13.2% 15.2% 11.6% EBIT 164.5 136.1 133.5 96.7 in % of sales 15.2% 12.4% 12.3% 8.8% Financial Result -11.7
Slide 35: Balance Sheet and Maturity Profile
Balance Sheet and Maturity Profile L.
Slide 36: Working capital
EUR million 400 18.1% 18.3% 18.5% 18.1**% 20% 17.4% 17.1% 17.5% 16.1% 16.5% 15.6% 300 143 14.8% 162 15% 15.0% 153 13.2% 200 13.8% 123 13.9% 124 15.5% 108 13.9% 81 13.1% 79 14.2% 90 100 14.3% 70 178 173 10% 11.5% 12.6% 16.5% 115 14.6% 130 15.6% 140 14.9% 151 16.4% 15.7% 13.2% 12.3% 80 65 67 74 0 -6.3
Slide 37: Equity development
• Equity increased by EUR 27 million with profit of EUR 58 million • Dividend payment in 2019 for 2018 of EUR 35 million EUR million 700 -35 6* 600 58 500 400 300 600** 629 200 100 0 Equity 2018 Profit Dividend Others* Equity 2019 * mainly exchange differences on translation of foreign operations of
Slide 38: Net debt and leverage
• Leverage increases to 2.2 (2018: 1.9) and net debt increases by 5.1% to EUR 421 million including dividend payment of EUR 35 million an EUR 39 million due to IFRS 16 in EUR million 400 421 600 (Net debt / 1.9 x adjusted EBITDA) 400 590 (Net debt / equity) 0.7 x 601 200 0 -190 -180 -200 Dec 31, 201
Slide 39: Debt maturity profile
400 Bank Borrowings Promissory Note 1 Promissory Note 2 Promissory Note 3 CP Program 300 45 200 100 248 15 65 42 0 29 35 21 42 2020 2021 2022 2023 2024 2025 2026 400 USD 300 EUR 109 200 100 12 184 51 44 49 52 41 0 2020 2021 2022 2023 2024 2025 2026 39
Slide 40: Balance sheet
Goodwill / Other intangible assets Total equity 602.5 916.2 / Property, plant & equipment Other non-financial assets / Derivative financial assets / 12.1 Retirement benefit obligations / Deferred- and income tax assets 28.8 Provisions Total non-current assets 928.3 Borrowings and 589.9 other financi
Slide 41: Cash Flow & NORMA Value Added
Cash Flow & NORMA Value Added
Slide 42: Net operating cash flow
Adjusted EBITDA 117.0 120.8 129.3 138.4 177.5 179.4 199.7 201.4 187.2 -7.1% Δ ± Trade Working capital -19.5 -9.8 +5.1 +10.4 -0.6 +17.0 -19.1 -13.7 -9.5 -30.7% 97.5 111.0 134.4 148.8 176.9 196.4 180.6 187.7 -5.3% Δ ± Investments from operating -30.7 -30.0 -30.5 -39.6 -42.2 -47.9 -47.7 -63.3 -54.8 -13
Slide 43: NORMA Value Added (NOVA)
• The NORMA Value Added (NOVA) is NORMA Group‘s long term strategic target Adjusted EBIT after taxes 123.5 98.4 • NORMA Group determines the annual value • creation in form of the so called NORMA Value Added Capital Cost (WACC x CE per January 1st) -62.8 -81.1 (NOVA) • NOVA is calculated on the basi
Slide 44: Get on Track and Strategy
Get on Track and Strategy
Slide 45: Rightsizing program
Optimization of the production landscape, which has grown rapidly as a result of acquisitions, organizational structures and further harmonization of processes and systems worldwide The optimization measures have been extended across all regions and also supraregional Further development of the busi
Slide 46: Get on track change program
Change program will set basis for further strategic development and profitable growth of NORMA Group Key objective to return NORMA to historic profit margin levels Start execution of holistic performance program to increase efficiency and achieve full profit potential across NORMA Group Alignment of
Slide 47: Get on track measures
• Increase share of best cost country production • Reduction of complexity • Streamlining of product portfolio through active portfolio management • Bundle and transfer low volume products and business to wholesaler • Strengthen commodities strategy • Focus on best cost country purchasing • Improvem
Slide 48: Cost volume of the change program
In EUR million 50 • Accumulated total cost 5 volume for implementation of around EUR 55 million until 2023. 25 • Implementation costs will be shown on an unadjusted basis. 20 Locations Structures & Processes Product Portfolio 48
Slide 49: Get on track program accelerated
• "Get on track" program accelerated also due to COVID-19 pandemic • EUR 23.7 million costs in Q1-Q3 2020 related to location projects lead to increased costs in 2020 of EUR 30 million • First benefits include improvements in purchasing and product portfolio 2020 2021 2022 2023 2024 ongoing 60 ~50 ~
Slide 50: Strategic priorities
Execution of rightsizing- and "Get on track"-projects as a foundation of further profitable 1 growth 2 Expanding water business 3 Continue to develop product and service solutions for Continue to explore business opportunities particularly in Asia-Pacific to expand localization 4 and further improve
Slide 51: Business Model and Track Record
Business Model and Track Record
Slide 52: Global market and technology leader in joining and fluid handling
Global market and Offers more than 40,000 technology leader in joining NORMAFLUID ® innovative joining solutions in Delivers to more than and fluid handling 42% product categories: three 10,000 customers in 100 technology. Water, Fluid, Fasten. countries. NORMACONNECT ® Operates a global network 32%
Slide 53: Engineered Joining Technology in attractive markets
Engineered Joining Technology in the attractive markets water management, e-mobility and general industry Strong development and growth opportunities in water management and e-mobility Enhanced stability through broad diversification across products, end markets and regions Engineered products with
Slide 54: Product and service advantages
• Continuous new developments on a • Superior service level through global level in order to fulfill fleet worldwide presence and regional consumption regulations and cope sales hubs. with increased awareness in public perception. • Comprehensive customized • Ongoing trend in many product portfolio:
Slide 55: Asia-Pacific and water business expansion
• 20% of sales or EUR 218.1 million in 2019 • Production and distribution sites in Australia, Malaysia, the US and India • Expanding Water Business organically and through M&A transactions Acq.: Chien Jin Plastic (MYS) Acq.: Guyco (AUS) Acq.: NDS (USA) Acq.: Kimplas (IND) Acq.: Davydick & Co (AUS) →
Slide 56: Water management business split
Efficient Landscape Irrigation ca. 27% Stormwater Management ca. 61% Flow Management and Others ca. 12% 56
Slide 57: NDS wholesale and retail business
• More than 4,950 products • Over 15,800 customer locations (retail and wholesale customers) • Three production sites (CA), six warehouses in the US, more than 500 employees • Orders received by 11 am are shipped the same day for wholesale orders • 97% order fill rate, 98% on-time shipment of orders
Slide 58: Water management market
Watermanagement Market for Joining and Fluid Handling Technology Stormwater Management Efficient Landscape Irrigation Flow Management and Others 58
Slide 59: E-mobility growth perspectives
Battery Thermal Management Growth Coolant Systems perspec- tives Power Electronics and Motors Cooling HVAC / Heat Pump Systems Combustion engine Thermal applications management Battery New applications battery engine Cooling Production volume in million System / HVAC 110 9.5 10.4 Thermal 8.6 Engine
Slide 60: Tightening emission regulations
• Environmental awareness continues to drive tightening emission regulations globally, including in emerging markets • Low-emission alternatives require significantly higher joining technology content at a substantially increased complexity compared to existing/past technologies 60
Slide 61: Unique business model with two ways-to-market
High quality, branded and standardized Innovation and product solution partner for joining products provided at competitive customers, focused on engineering prices to broad range of customers. expertise with high value-add. Unique business model with two distinct ways-to-market • Significant econom
Slide 62: Additional growth for joining technology market
Sales in EUR million (year)* 1200 Additional growth for Joining Technology 1,100 market above market growth 1000 ca. Water ( ca. 20%) / Fluid ( ca. 30%) 800 50% Passenger vehicles 600 Commercial vehicles ca. Fasten 50% 360 400 Agricultural equipment 200 Add. 2-4% 65 64 60 36 30 24 21 Construction eq
Slide 63: Basis for premium pricing
Basis for premium pricing Market leadership Technology Quality Innovation Tailor-made solutions ca. EUR 224 content per vehicle in total ca. EUR 95 in other application areas < 0.1% content per vehicle ca. EUR 350,000 ca. EUR 24 ca. EUR 82 costs an average ca. EUR 23 in the cooling in the exhaust ha
Slide 64: Products, locations and customers
Construction / Construction Engines Commercial vehicles infrastructure / water Passenger vehicles equipment management Wholesalers & Agricultural equipment Shipbuilding HVAC Pharma & Biotech technical distributors • More than 40,000 products, manufactured in 28 locations and sold to more than 10,000
Slide 65: Cost of product failure
• Reputation loss • Image loss • Warranty costs • Non-compliance with legal requirements/regulations 65
Slide 66: Company history and milestones
Acquisition Acquisition 2018 Kimplas, India Statek, Germany Acquisition Acquisition 2017 Lifial, Portugal Fengfan, China Acquisition 2016 Autoline Business, France Foundation Acquisition Acquisition National 2014 NORMA China II Five Star, USA Diversified Sales, USA 2011 Acquisition Acquisition Varia
Slide 67: Acquisitions
CONNECTORS Verbindungstechnik AG, Switzerland 04/12 Market entry in connecting technology in Pharma & Biotech 16.6 Nordic Metalblok S.r.l., Italy 07/12 Market consolidation heating and air conditioning clamps 5.2 Chien Jin Plastic Sdn. Bhd., Malaysia 11/12 Market entry joining elements for water dis
Slide 68: Global footprint
EMEA Czech Republic (P) France (P, D) Germany (P, D) Italy (D) Netherlands (D) Poland (P, D) Portugal (P) Russia (D) Serbia (P) Spain (D) Sweden (P, D) Switzerland (P, D) Turkey (D) United Kingdom (P, D) Americas Brazil (P, D) Mexico (P, D) USA (P, D) Asia-Pacific Australia (D) China (P, D) India (P
Slide 69: Management Board
Chairman of the Management Board, Member of the Management Board, Member of the Management Board, CEO of NORMA Group SE COO of NORMA Group SE CFO of NORMA Group SE since November 14, 2019 since October 1, 2018 since October 1, 2020 Responsibilities: Responsibilities: Responsibilities: Group Developm
Slide 70: Track record 2008-2019
of sales 1200 700 65% 61.0% 59.1% 57.8% 57.3% 59.9% 600 58.4% 58.4% 57.0% 60% 900 500 54.9% 55.3% 56.0% 55.5% 400 55% 600 1,084 1,100 1,017 300 601 627 631 890 895 533 546 50% 636 695 200 406 300 581 605 323 344 371 458 490 251 275 45% 330 100 182 0 0 40% 2008 2009 2010 2011 2012 2013 2014 2015 2016
Slide 71: Working capital and factoring track record
EUR million EUR million 160 of sales 400 18.1% 18.3% 18.5% 17.4% 18.1% 17.1% 17.5% 20% 140 16.1% 15.6% 16.5% 120 162 15% 153 143 100 200 123 124 108 80 70 81 79 90 10% 149 130 140 151 178 173 135 133 65 67 74 80 115 60 124 123 0 104 109 -46 -41 -38 -59 -81 -101 -120 5% 40 81 -146 -142 -143 67 62 67
Slide 72: Corporate Responsibility
[oNSER Corporate @ Responsibility US7
Slide 73: CR Policy
Find all details in • Compliance NORMA Group’s CR • Anti-Discrimination Policy • Freedom of Association • Awareness of CR • Health & Safety • NORMA Clean Water • Training & Development • NORMA Help Day • Remuneration & Employee • Donations & Sponsoring Satisfaction • Diversity • Climate • Quality •
Slide 74: UN Global Compact and CR governance
Membership with UN Global Compact • Ten principles in the areas of human rights, labor, the environment and anti-corruption Management Board Human and Labor Rights • “NORMA Group categorically rejects and does not accept any form of violation of human rights.” Corporate Responsibility Signatory of D
Slide 75: Approach to sustainability
NORMA Group’s approach to sustainability / corporate responsibility [a Stakeholder communication (onson* TIE —— CHANGING management E=] vY audited
Slide 76: Share & Shareholders
Share & Shareholders
Slide 77: Shareholder structure
Allianz Global Investors GmbH, Frankfurt am Main, Germany 15.20% Ameriprise Financial Inc., Wilmington, DE, USA 4.83% 31% Impax Asset Management Group Plc, London, United Kingdom 5.08% 14% T. Rowe Price Group, Inc.., Baltimore, Maryland, US 5.01% Threadneedle Management Luxembourg S.A. 4.90% 8% 22%
Slide 78: Share price performance
80 60 40 20 0 -20 -40 -60 -80 Dez. 18 Mrz. 19 Jun. 19 Sep. 19 Dez. 19 Mrz. 20 Jun. 20 Sep. 20 NORMA Group DAX MDAX SDAX MSCI World Automobil 78
Slide 79: Financial calendar and contact
Publication of Preliminary Full Year 2020 Results February 17, 2021 Publication of Full Year 2020 Results March 24, 2021 Publication of Interim Results Q1 2021 May 5, 2021 Annual General Meeting May 20, 2021 Publication of Interim Results Q2 2021 August 4, 2021 Publication of Interim Results Q3 2021
Slide 80: Disclaimer
This presentation contains certain future-oriented statements. Future-oriented statements include all statements which do not relate to historical facts and events and contain future-oriented expressions such as ‘believe,’ ‘estimate,’ ‘assume,’ ‘expect,’ ‘forecast,’ ‘intend,’ ‘could’ or ‘should’ or